Baclofen
NDC 67296-1882
Product Information
Baclofen is a ANDA-approved product labeled by Redpharm Drug, Inc. Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It is supplied as a white product. This product entry covers the primary NDC 67296-1882 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
I115
Code Structure Chart
Product Details
What is NDC 67296-1882?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BACLOFEN (UNII: H789N3FKE8)
- BACLOFEN (UNII: H789N3FKE8) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- ZINC STEARATE (UNII: H92E6QA4FV)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 197392 - baclofen 20 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.
Patient Education
Baclofen
Baclofen is used to treat pain and certain types of spasticity (muscle stiffness and tightness) from multiple sclerosis, spinal cord injuries, or other spinal cord diseases. Baclofen is in a class of medications called skeletal muscle relaxants. Baclofen acts on the spinal cord nerves and decreases the number and severity of muscle spasms caused by multiple sclerosis or spinal cord conditions. It also relieves pain and improves muscle movement.
[Learn More]
* Please review the full disclaimer at the bottom of this page.